Cancer-related fatigue shows a stable association with diurnal cortisol dysregulation in breast cancer patients
Fatigue is a major burden for breast cancer patients undergoing adjuvant therapy. Yet, its pathophysiology is still not well understood. Hypothesized mechanisms include dysregulations in the hypothalamic-pituitary-adrenal (HPA) axis, which may be reflected in alterations in the diurnal cortisol patt...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2016
|
| In: |
Brain, behavior and immunity
Year: 2015, Volume: 52, Pages: 98-105 |
| ISSN: | 1090-2139 |
| DOI: | 10.1016/j.bbi.2015.10.005 |
| Online Access: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.bbi.2015.10.005 Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0889159115300301 |
| Author Notes: | Martina E. Schmidt, Johanna Semik, Nina Habermann, Joachim Wiskemann, Cornelia M. Ulrich, Karen Steindorf |
| Summary: | Fatigue is a major burden for breast cancer patients undergoing adjuvant therapy. Yet, its pathophysiology is still not well understood. Hypothesized mechanisms include dysregulations in the hypothalamic-pituitary-adrenal (HPA) axis, which may be reflected in alterations in the diurnal cortisol patterns. However, studies on the association between cortisol and fatigue during adjuvant cancer therapy are rare. |
|---|---|
| Item Description: | Available online 9 October 2015 Gesehen am 19.05.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1090-2139 |
| DOI: | 10.1016/j.bbi.2015.10.005 |